Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00367445 · ClinicalTrials.gov registry record · Phase 4
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00367445: Completed Phase 4 study, sponsored by Pfizer.
NCT00367445 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00367445, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus
Interventions
- DRUG Inhaled Human Insulin (Exubera)
- DRUG Insulin Glargine (Lantus)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-02 |
| Phase | Phase 4 |
What the finished NCT00367445 record still lists
NCT00367445 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Inhaled Human Insulin (Exubera) is the first listed.
NCT00367445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00367445 about?
NCT00367445 is a clinical study titled "A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus". To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus
What is the current status of trial NCT00367445?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2006-09. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00367445?
The interventions under investigation include: Inhaled Human Insulin (Exubera) (DRUG), Insulin Glargine (Lantus) (DRUG).
Who is sponsoring clinical trial NCT00367445?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00367445's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia